Navigation Links
Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management
Date:6/5/2008

TORONTO, June 5 /PRNewswire/ -- Genzyme Corporation (Nasdaq: GENZ), one of the world's leading biotechnology companies, is enhancing the quality of the medical devices produced in its Bio-surgery division with software from Dyadem, the leader in Risk Lifecycle Management and Quality Lifecycle Management. Dyadem's FMEA-Med, a software solution that helps automate compliance reporting, enables Genzyme to link risk and quality, and to set a new standard in quality throughout the lifecycle of its biotherapeutic and biomaterial products. Genzyme's leading biomaterials and cell therapies reduce the time and complications associated with surgery, and in some cases, postpone the need for surgery.

FMEA-Med is a software solution that delivers industry-standard Failure Mode and Effects Analysis (FMEA) reports for medical devices and pharmaceutical manufacturers. FMEA methodology maintains quality and prevents potential flaws in hardware design, manufacturing and processes in a variety of industries, including pharmaceutical, automotive, and high-tech and electronics. Dyadem's FMEA-Med focuses on the entire quality lifecycle management process, which is essential to the research and advancement of these fields. The medical device industry must comply with FDA and ISO standards among others.

With more than 300 employees spanning three sites in the United States, Genzyme's Bio-surgery division now has a single standard for risk assessment. As these multiple sites are subject to varying government and industry regulatory standards, Genzyme's use of FMEA-Med creates a consistent quality standard across the division to fulfill the varying requirements.

Prior to selecting Dyadem, Genzyme used manual templates for FMEA assessments. Gen
'/>"/>

SOURCE Dyadem
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Awareness of Genzymes Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected
2. Genzyme Reports Strong First-Quarter Growth
3. Genzyme to Build New R&D Center in Beijing
4. Genzyme Provides Update on Myozyme(R) Manufacturing
5. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
6. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
7. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
8. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
9. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
10. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
11. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... focused on the development of autologous cell therapies, announced today ... at the InvestMNT conference held in Minneapolis, Minnesota ... local time. Hall,s presentation will highlight RepliCel,s 18-month milestones including ... Europe , clinical data from both RCT-01 ...
(Date:7/31/2015)... HONG KONG , July 31, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... with the U.S. Securities and Exchange Commission. The filed ... year ended March 31, 2015. The Form 20-F can ...
(Date:7/30/2015)...   GenoSpace , a leading provider of ... of genomic and other biomedical data, today announced ... company as Vice President of Sales and Marketing. ... "GenoSpace partners with its customers to ... explore complex sets of genomic, phenotypic and other ...
(Date:7/30/2015)... Diego , CA (PRWEB) , ... July 30, ... ... announced the successful completion of a field clinical study of its canine osteoarthritis ... developed together with Aratana Therapeutics (Kansas City, KS) and will be marketed in ...
Breaking Biology Technology:RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... Cell Therapeutics, Inc. ("the Company") (Nasdaq and MTA: CTIC) ... up results from the Company,s pivotal phase III PIX301 ... recent Marketing Authorization Application (the "MAA") currently under review ... end-of-study results showed continued improvement in the trial,s primary ...
... 2010 Gentiva Health Services, Inc. (Nasdaq: ... and hospice services, announced today that it has scheduled a ... 10:00 a.m. ET to provide an update on its 2011 ... of December 16 before pre-market trading. The December ...
... 3, 2010 Nu Skin (NYSE: NUS ... physical vitality is improved through nutritional strategies that influence ... the First World Congress on Targeting Mitochondria: Strategies, Innovation ... Nu Skin,s innovative ageLOC science we have successfully identified ...
Cached Biology Technology:New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 2New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 3New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 4New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 5New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 6Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 2Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010 3Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria 2Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria 3
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... has found that the red squirrel population along the ... outbreak of squirrelpox in 2008. Researchers from the ... been monitoring the red squirrel population at the Seaforth ... 85% fall in the red squirrel population. Squirrel ...
... STOCKHOLM , November 26, 2013 ... et en extérieur dans plus de 30 pays ... en Suède, vient de lancer Trax, un traceur GPS ... appareil intelligent et son application permettent aux utilisateurs de ...
... Barbara, Calif.) Sepsis, the body,s response to severe ... and HIV/AIDS combined. On average, 30 percent of those ... by Jamey Marth, director of UC Santa Barbara,s Center ... Institute, reports a new method to increase survival in ...
Cached Biology News:Red Squirrels showing resistance to squirrelpox 2Suivez vos enfants et vos animaux domestiques grâce à TRAX, le nouveau traceur GPS intelligent 2Suivez vos enfants et vos animaux domestiques grâce à TRAX, le nouveau traceur GPS intelligent 3UCSB biomedical scientist discovers a new method to increase survival in sepsis 2UCSB biomedical scientist discovers a new method to increase survival in sepsis 3
S-100 alpha/beta chain (8B10)...
... a new product number, created to ... showing no availability yet, please order ... or contact customer service for assistance. ... mm, No. of sidearm 4 ...
... 15(S)-15-methyl PGF2α is a ... It is a potent uterine ... be administered intramuscularly to induce ... reduces serum progesterone concentrations when ...
TGase3 (S-20)...
Biology Products: